Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.

Westwood, Jennifer A

Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Jan 2004 - 757-61 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0022-1767

10.4049/jimmunol.172.2.757 doi


Animals
CD4-Positive T-Lymphocytes--immunology
Cell Line, Tumor
Cytotoxicity, Immunologic--genetics
Graft Rejection--immunology
Immunity, Cellular--genetics
Immunity, Innate--genetics
Immunization, Secondary
Immunologic Memory--genetics
Injections, Subcutaneous
Killer Cells, Natural--immunology
Lymphoma, T-Cell--immunology
Mice
Mice, Inbred C57BL
Mice, Knockout
NK Cell Lectin-Like Receptor Subfamily K
Neoplasm Transplantation
Receptors, Immunologic--physiology
Receptors, Natural Killer Cell
T-Lymphocytes, Regulatory--immunology
Th1 Cells--immunology